Loading clinical trials...
Loading clinical trials...
IOXSOR study's purpose to determine the frequency of non resolutive renal failure (estimated by the clearance of iohexol) at end of stay in ICU patients who have had acute renal failure episode.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Angers
NCT05282732 · Renal Failure, End Stage Renal Disease, and more
NCT04334707 · Acute Kidney Failure, Acute Kidney Insufficiency, and more
NCT01682590 · Septic Shock, Acute Renal Failure (as Defined by the "Failure" Stage of the RIFLE Classification)
NCT01467466 · Acute Renal Failure, Kidney Disease, and more
NCT06926946 · Acute Renal Failure, Neonatal Morbidity
University Hospital
Angers
Hospital center
Chartres
Hospital
Le Mans
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions